Is viability still viable after the STICH trial?

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 3, 2012, Pages 219-226

  Cortigiani, Lauro ^a   Bigi, Riccardo ^b   Sicari, Rosa ^c  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Myocardial viability; Prognosis; Revascularization

Indexed keywords

DOBUTAMINE;

ACUTE CORONARY SYNDROME; BLOOD CLOT LYSIS; CARDIAC IMAGING; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY; STUNNED HEART MUSCLE; SURVIVAL;

CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; PROGNOSIS; TISSUE SURVIVAL; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84863828007     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ejechocard/jer237     Document Type: Review

References (73)

1. The Multicenter Post Infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
2. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. Circulation 1993;88:416-29. (Pubitemid 23228040)
3. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9. (Pubitemid 13238825)
4. Pierard L, Picano E. Myocardial viability. In: Picano E, ed. Stress Echocardiography. 5th ed. Heidelberg: Springer-Verlag, 2009:273-94.
5. Solomon SD, Glynn RJ, Ajani U, Rouleau JL, Menapace F et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Ann Intern Med 2001;134:451-8. (Pubitemid 32225946)
6. Smart SC, Sawada S, Ryan T, Segar D, Atherton L, Berkovitz K et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15. (Pubitemid 23228039)
7. Piérard LA, De Landersheere CM, Berthe C, Rigo P, Kulbertus HA. Identification of viable myocardium during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31. (Pubitemid 20104557)
8. Watada H, Ito H, Oh H, Aburaya M, Hori M, Iwakura M et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994;24:624-30. (Pubitemid 24295734)
9. Poli A, Previtali M, Lanzarini L, Fetiveau R, Diotallevi P, Ferrario M et al. Comparison of dobutamine stress echocardiography with dipyridamole echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis. Heart 1996;75:240-6. (Pubitemid 26094961)
10. Dionisopoulos P, Smart SC, Sagar KB. Dobutamine stress echocardiography predicts left ventricular remodeling after acute myocardial infarction. J Am Soc Echocardiogr 1999;12:777-84. (Pubitemid 29489401)
11. Nijland F, Kamp O, Verhorst PM, de Voogt WG, Bosch HG, Visser CA. Myocardial viability: impact on left ventricular dilatation after acute myocardial infarction. Heart 2002;87:17-22. (Pubitemid 34074944)
12. Coletta C, Sestili A, Seccareccia F, Rambaldi R, Ricci R, Galati A et al. Influence of contractile reserve and inducile ischaemia on left ventricular remodelling after acute myocardial infarction. Heart 2003;89:1138-43. (Pubitemid 37163997)
13. Bolognese L, Cerisano G, Buonamici P, Santini A, Santoro GM, Antoniucci D et al. Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction. Circulation 1997;96:3353-9. (Pubitemid 27513405)
14. St. John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moyé LA, Dagenais GR et al. Quantitative two dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circulation 1994;89:68-75. (Pubitemid 24026473)
15. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM et al. Left ventricular remodeling after primary coronary angioplasty. Patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106: 2351-7. (Pubitemid 35244737)
16. Rossi A, Cicoira M, Anselmi M, Golia G, Latina L, Tinto M et al. Myocardial viability independently influences left ventricular diastolic function in the early phase after acute myocardial infarction. J Am Soc Echocardiogr 2002;15:1490-5. (Pubitemid 36519672)
17. Picano E, Sicari R, Landi P, Cortigiani L, Bigi R, Coletta C et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction. A dobutamine stress ecocardiographic study. Circulation 1998;98:1078-84. (Pubitemid 28420699)
18. Sicari R, Picano E, Landi P, Pingitore A, Bigi R, Coletta C et al. The prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardiol 1997;29:254-60. (Pubitemid 27059952)
19. Bigi R, Desideri A, Bax JJ, Galati A, Coletta C, Fiorentini C et al. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. Am J Cardiol 2001;87:283-8. (Pubitemid 32144867)
20. Bigi R, Cortigiani L, Desideri A, Colombo P, Sponzilli C, Bax JJ et al. Clinical and angiographic correlates of dobutamine-induced wall motion patterns after myocardial infarction. Am J Cardiol 2001;88:944-8. (Pubitemid 33042601)
21. Villanueva FS. Myocardial contrast echocardiography in acute myocardial infarction. Am J Cardiol 2002;90(suppl):38J-47J. (Pubitemid 35346867)
22. Zoghbi WA. Evaluation of myocardial viability with contrast echocardiography. Am J Cardiol 2002;90(suppl):65J-71J. (Pubitemid 35346870)
23. Bolognese L, Antoniucci D, Rovai D, Buonamici P, Cerisano G, Santoro GM et al. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol 1997;28:1677-83.
24. Hillis GS, Mulvagh SL, Pellikka PA, Hagen ME, Gunda M, Wright RS et al. Comparison of intravenous myocardial contrast echocardiography and low-dose dobutamine echocardiography for predicting left ventricular functional recovery following acute myocardial infarction. Am J Cardiol 2003;92:504-8. (Pubitemid 37013399)
25. Ueno Y, Nakamura Y, Kinoshita M, Fujita T, Sakamoto T, Okamura H. Can coronary flow velocity reserve determined by transthoracic doppler echocardiography predict the recovery of regional function in patients with acute myocardial infarction? Heart 2002;88:137-41. (Pubitemid 34787761)
26. Rigo F, Zuin G, Varga ZS, Grassi G, Turiano G, Zuin G et al. Early assessment of coronary flow reserve by transthoracic Doppler echocardiography predicts late remodeling in reperfused anterior myocardial infarction. J Am Soc Echocardiogr 2004;17:750-5. (Pubitemid 38858023)
27. Meimoun P, Boulanger J, Luycx-Bore A, Zemir H, Elmkies F, Malaquin D et al. Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular adverse remodelling. Eur J Echocardiogr 2010;11:711-8.
28. Nohtomi Y, Takeuchi M, Nagasawa K, Arimura K, Miyata K, Kuwata K et al. Persistence of systolic coronary flow reversal predicts irreversible dysfunction after reperfused anterior myocardial infarction. Heart 2003;89:382-8. (Pubitemid 36379408)
29. Yamamuro A, Akasaka T, Tamita K et al. Coronary flow velocity pattern immediately after percutaneous coronary intervention as a predictor of complications and in-hospital survival after acute myocardial infarction. Circulation 2002;106: 3051-6. (Pubitemid 35440287)
30. Braunwald E, Rutherford D. Reversible ischemic left ventricular dysfunction: evidence for 'hibernating' myocardium. J Am Coll Cardiol 1986;8:978-85.
31. Heart Disease and Stroke Statistics 2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e1-e16129.
32. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998;97:282-9. (Pubitemid 28067315)
33. Cwaig JM, Cwaig E, Nagueh SF, He ZX, Qureshi U, Olmos LI et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation with rest-redistribution Tl-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 2000;35:1152-61. (Pubitemid 30206889)
34. Yong Y, Nagueh SF, Shimoni S, Shan K, He ZX, Reardon MJ et al. Deceleration time in ischemic cardiomyopathy: relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization. Circulation 2001;103:1232-7. (Pubitemid 32221345)
35. Bax JJ, Schinkel AF, Boersma E et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004;110(11 Suppl 1):II18-22. (Pubitemid 39263692)
36. Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Reijs AE et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress- reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996;28: 558-64.
37. Rizzello V, Poldermans D, Schinkel AF, Biagini E, Boersma E, Elhendy A et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 2006; 92:239-44. (Pubitemid 43131969)
38. Bonow RO. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2002;39:1159-62. (Pubitemid 34267419)
39. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-53.
40. Charney R, Schwinger ME, Chun I, Cohen MV, Nanna M, Menegus MA et al. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128:864-9. (Pubitemid 24344982)
41. Perrone-Filardi P, Pace I, Prastaro M, Piscione F, Betocchi S, Squame F et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;90:2556-65.
42. Arnese M, Cornel JH, Salustri A, Maat A, Elhendy A, Reijs AE et al. Prediction of improvement of regional left ventricular function after surgical revascularization; a comparison of low-dose dobutamine echocardiography with 201-Tl singlephoton emission computed tomography. Circulation 1995;90:2748-52.
43. Haque T, Furukawa T, Takahashi M, Kinoshita M. Identification of hibernating myocardium by dobutamine stress echocardiography: comparison with thallium-201 reinjection imaging. Am Heart J 1995;130:553-63.
44. Baumgartner H, Porenta G, Lau YK, Wutte M, Klaar U, Mehrabi M et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol 1998;32:1701-8. (Pubitemid 28545211)
45. Hensch G, Schultz R. The biology of myocardial hibernation. Trends Cardiovasc Med 2000;10:108-14.
46. Buckley O, Di Carli M. Predicting benefit from revascularization in patients with ischemic heart failure: imaging of myocardial ischemia and viability. Circulation 2011;123:444-50.
47. Picano E. Sustainability of medical imaging. BMJ 2004;328:578-80. (Pubitemid 38316634)
48. Wellnhofer E, Olariu A, Klein C et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109:2172-4. (Pubitemid 38625392)
49. Bove CM, DiMaria JM, Voros S, Conaway MR, Kramer CM. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting-initial experience. Radiology 2006;240:835-41. (Pubitemid 44267342)
50. Carluccio E, Biagioli P, Alunni G et al. Patients with hybernating myocardium show altered left ventricular volumes and shape, which revert after revascularization. J Am Coll Cardiol 2006;47:969-77.
51. Meluzin J, Cezny J, Frelich M et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1998;32:912-20. (Pubitemid 28459578)
52. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998;32:921-6. (Pubitemid 28459579)
53. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts longterm survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848-54.
54. Sawada S, Bagat A, Vaz D et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgical revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 2003;42:2106-28.
55. Bax JJ, Poldermans D, Elhendy A et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
56. Chaudry FA, Tauke JT, Alessandrini RS, Vardi J, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999;34:730-8. (Pubitemid 29436178)
57. Sicari R, Picano E, Cortigiani L et al. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 2003;92:1263-6. (Pubitemid 37431131)
58. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin JA, Vanovershelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999;100:141-8. (Pubitemid 29330012)
59. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-8.
60. Haffner SM, Letho S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34. (Pubitemid 28350165)
61. Cortigiani L, Bigi R, Sicari R, Landi P, Bovenzi F, Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 2006;47: 605-10. (Pubitemid 43170852)
62. Herlitz J, Wognsen GB, Emanuelsson H et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 1996;19:698-703. (Pubitemid 126752470)
63. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 2002;40:418-23. (Pubitemid 34833154)
64. Rizzello V, Poldermans D, Biagini E et al. Benefits of coronary revascularization in diabetic and non-diabetic patients with ischemic cardiomyopathy: role of myocardial viability. Eur J Heart Fail 2006;8:314-20.
65. Cortigiani L, Sicari R, Desideri A et al. Dobutamine stress echocardiography and the effect of revascularization on outcome in diabetic and non-diabetic patients with chronic ischaemic left ventricular dysfunction. Eur J Heart Fail 2007;9: 1038-43. (Pubitemid 47451808)
66. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8. (Pubitemid 34267418)
67. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-14. (Pubitemid 350301145)
68. Bonow RO, Maurer G, Lee KL et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364:1617-25.
69. Mack MJ. How should the STICH trial results affect clinical practice. Nat Rev Cardiol 2011;8:427-8.
70. Eichhorn EJ, Grayburn PA, Mayer SA et al. Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST). Circulation 2003;108:2336-41. (Pubitemid 37413539)
71. Schinkel A, Bax JJ, Delgado V, Poldermans D, Rahimtoola SH. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction. Am J Med 2010; 123:978-86.
72. Ciampi Q, Pratali L, Citro R, Piacenti M, Villari B, Picano E. Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography. Eur J Heart Fail 2009;11:489-96.
73. American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians, Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. J Am Soc Echocardiogr 2011;24:229-67.